基于循环氧基因酶-2/p53轴的性结肠炎中的预防和治疗进展
Yi-Lin Zhang1, Shu-Sen Yang1, Yu-Shan Liu1
1Basic Medical College of Shaanxi University of Chinese Medicine,Xianyang,Shaanxi 712046,China.
概括
性结肠炎 (UC) 通过发育不良增加了结肠直肠癌的风险. 准循环氧化酶-2 (COX-2) 和p53通路可能会恢复肠道细胞平衡并预防癌症的发展.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,与结直肠癌风险增加有关.
- 由于细胞增殖/细胞亡不平衡导致的发育不良,将慢性肠道炎症与结直肠癌联系起来.
- 循环氧化酶-2 (COX-2) 和p53通路与UC相关的细胞失生症中出现的异常细胞行为有关.
研究的目的:
- 研究COX-2和p53在UC相关的肠粘膜上皮细胞增殖和亡中的作用.
- 阐明COX-2和p53影响UC发育失生症的机制.
- 为开发针对UC诱导的发育障碍和结直肠癌的向治疗提供基础.
主要方法:
- 关于UC,发育不良,COX-2和p53的现有文献的审查.
- 在UC的背景下分析细胞增殖,细胞亡,COX-2和p53之间的相互作用.
- 讨论针对COX-2/p53轴进行治疗干预的可能性.
主要成果:
- 细胞增殖/细胞亡不平衡是UC的发育不良症的关键驱动因素.
- 无论是COX-2还是p53,都是肠道粘膜上皮细胞中这种不平衡的潜在调节者.
- 对COX-2/p53轴的调节失调有助于从慢性炎症的进展到发育不良和癌症.
结论:
- 在UC中,COX-2/p53轴在调节肠粘膜细胞平衡方面发挥着至关重要的作用.
- 针对COX-2/p53通路提供了潜在的治疗策略,用于管理UC相关的发育不良.
- 了解这些分子机制对于预防UC患者结直肠癌至关重要.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
116
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
342
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
342
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
01:26Peptic Ulcer Disease IV: Management
72
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
72
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
353
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
353
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
135
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135